IPO | Science and Enterprise

A group of Canadian academic labs and hospitals will begin a clinical trial testing antibodies from recovered Covid… https://t.co/BsfaYEhTGM
about 4 hours ago
New post on Science and Enterprise: Trial to Test Convalescent Antibodies for Covid-19 https://t.co/tWxVos72rq #Science #Business
about 4 hours ago
A company developing cancer immunotherapies is adapting its electronic-assisted process to create a vaccine protect… https://t.co/4Xg2tQlV57
about 1 day ago
New post on Science and Enterprise: Trial to Test Electronic-Aided Covid-19 Vaccine https://t.co/RPHi8QpchO #Science #Business
about 1 day ago
An industry group says rules for loans to small companies hard-hit by Covid-19 are changed to allow these loans for… https://t.co/k8OZb84rcC
about 1 day ago

Migraine Drug Developer Raises $82.5M in IPO

By Alan, on September 13th, 2019%

A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million in its initial public offering of common stock. . . . → Read More: Migraine Drug Developer Raises $82.5M in IPO

Two Biotechs Each Issue $300M+ IPOs

By Alan, on June 27th, 2019%

Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions. . . . → Read More: Two Biotechs Each Issue $300M+ IPOs

Genome Editing Biotech Raises $126M in IPO

By Alan, on March 28th, 2019%

A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock. . . . → Read More: Genome Editing Biotech Raises $126M in IPO

Infographic – Tech IPOs Flat in 2018

By Alan, on December 22nd, 2018%

CB Insights recently issued its annual Tech IPO Report, showing the number of initial public stock offerings in the technology industries unchanged from 2017. . . . → Read More: Infographic – Tech IPOs Flat in 2018

RNA Biotech Raises $604M in IPO

By Alan, on December 8th, 2018%

Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million. . . . → Read More: RNA Biotech Raises $604M in IPO

Synthetic DNA Company Raising $70 Million in IPO

By Alan, on October 31st, 2018%

A 5 year-old enterprise developing synthetic DNA for medical and agricultural chemicals, as well as data storage, is raising $70 million in its initial public stock offering. . . . → Read More: Synthetic DNA Company Raising $70 Million in IPO

Cancer T-Cell Start-Up Gains $150 Million in IPO

By Alan, on June 25th, 2018%

A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock. . . . → Read More: Cancer T-Cell Start-Up Gains $150 Million in IPO

Multi-Drug Resistance Antibiotic Developer to Issue IPO

By Alan, on October 24th, 2017%

A three year-old company making new antibiotics to treat infections resistant to earlier antibiotics plans to raise some $75 million in its initial public stock offering. . . . → Read More: Multi-Drug Resistance Antibiotic Developer to Issue IPO

Cancer Gene Therapy Company Raises $85M in IPO

By Alan, on April 13th, 2017%

A developer of cancer immunotherapies that transfer gene treatments into patients with brain tumors is raising $85 million in its initial public stock offering. . . . → Read More: Cancer Gene Therapy Company Raises $85M in IPO

Medical Robotics Company Crowdfunding IPO

By Alan, on March 15th, 2017%

A medical robotics company spun-off from labs at MIT is issuing its initial public stock offering through equity crowdfunding, aiming to raise $15 million. . . . → Read More: Medical Robotics Company Crowdfunding IPO

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise